Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmel Armon

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Neuroepidemiology|June 7, 2003
An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosisCarmel Armon
Neurology|January 30, 2009
SOD1 A4V familial ALS in North America: can understanding the past lead to a better future?Carmel Armon
Neurology|December 6, 2013
The underestimation of familial ALS and counseling patients with sporadic ALSCarmel Armon
Muscle & Nerve|January 23, 2016
Accrued somatic mutations (nucleic acid changes) trigger ALS: 2005-2015 updateCarmel Armon
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
Theme 1 Epidemiology and informaticsCarmel Armon
The New England Journal of Medicine|February 5, 2015
Management of withdrawal delirium (delirium tremens)Carmel Armon
Annals of Neurology|March 16, 2019
Smoking is a cause of amyotrophic lateral sclerosis. High low-density lipoprotein cholesterol levels? UnsureCarmel Armon
Neurology|September 10, 2008
A randomized controlled trial of resistance exercise in individuals with ALSCarmel Armon
Neurology|June 11, 2008
Reflections: neurology and the humanities. Three drawersCarmel Armon
Neurology|November 24, 2004
Excess incidence of ALS in young Gulf War veteransCarmel Armon
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Neuroepidemiology|June 7, 2003
An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosisCarmel Armon
Neurology|January 30, 2009
SOD1 A4V familial ALS in North America: can understanding the past lead to a better future?Carmel Armon
Neurology|December 6, 2013
The underestimation of familial ALS and counseling patients with sporadic ALSCarmel Armon
Muscle & Nerve|January 23, 2016
Accrued somatic mutations (nucleic acid changes) trigger ALS: 2005-2015 updateCarmel Armon
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
Theme 1 Epidemiology and informaticsCarmel Armon
The New England Journal of Medicine|February 5, 2015
Management of withdrawal delirium (delirium tremens)Carmel Armon
Annals of Neurology|March 16, 2019
Smoking is a cause of amyotrophic lateral sclerosis. High low-density lipoprotein cholesterol levels? UnsureCarmel Armon
Neurology|September 10, 2008
A randomized controlled trial of resistance exercise in individuals with ALSCarmel Armon
Neurology|June 11, 2008
Reflections: neurology and the humanities. Three drawersCarmel Armon
Neurology|November 24, 2004
Excess incidence of ALS in young Gulf War veteransCarmel Armon
Pageof 8